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Introduction
Salmonella sp. and Shigella sp infections are public
health threat worldwide, particularly in Sub-Saharan
Africa including in Rwanda. This study was done to
identify Salmonella sp. and Shigella sp. currently circu-
lating in Rwanda and determine their drug susceptibility
pattern.
Objectives
To determine the prevalence of Salmonella spp. and
Shigella spp. strains circulating in Rwanda and their sus-
ceptibilty pattern in Rwanda.
Methods
196 blood and 24 stool specimens from patients were
analyzed in Laboratory of Rwanda for culture isolation,
identification and drug-sensitivity testing.
Results
91 (92.2 %) of them were identified as Salmonella enterica
serovar Typhi, 10 were Shigella sp. The isolates were sub-
sequently subjected to antibiotic susceptibility tests and
the strains of S.Typhi isolates were found to be susceptible
to cefotaxime (100%), and ciprofloxacin (97.9 %) and resis-
tant to nalidixic acid (89.4%), cotrimoxazole (87.2%). With
regard to Shigella infections, the antibiotics which showed
100% susceptibility to all species identified were ciproflox-
acine, cefotaxime, ceftazidine.
Conclusion
The prevalent Salmonella strain circulating in Rwanda is
S.Typhi and two most useful drugs of choice to treat
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